| Rick Hummel Md Pc | |
|
11155 Dunn Rd 201n St Louis MO 63136 | |
| (314) 741-1400 | |
| (314) 741-0175 |
| Full Name | Rick Hummel Md Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 11155 Dunn Rd, St Louis, Missouri |
| Authorized Official Name and Position | Rick G Hummel (PRESIDENT) |
| Authorized Official Contact | 3147411400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rick Hummel Md Pc 11155 Dunn Rd 201n St Louis MO 63136 Ph: (314) 741-1400 | Rick Hummel Md Pc 11155 Dunn Rd 201n St Louis MO 63136 Ph: (314) 741-1400 |
| NPI Number | 1114104114 |
|---|---|
| Provider Enumeration Date | 01/22/2008 |
| Last Update Date | 05/01/2008 |
| Medicare PECOS PAC ID | 2860546538 |
|---|---|
| Medicare Enrollment ID | O20090814000034 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114104114 | NPI | - | NPPES |
| CI5813 | Other | MO | RR MEDICARE |
| 150936 | Other | MO | BC |
| 31886 | Other | MO | GHP |
| 202626305 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R3D69 (Missouri) | Primary |
| Provider Name | Vikas Sethi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780823559 PECOS PAC ID: 0042377160 Enrollment ID: I20090317000408 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Rick G Hummel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609955483 PECOS PAC ID: 0042364713 Enrollment ID: I20090814000031 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Paul A Schippers |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275786147 PECOS PAC ID: 5496931347 Enrollment ID: I20110511000176 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Cirese L Webster |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598100406 PECOS PAC ID: 7810113115 Enrollment ID: I20140722002638 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Bruce M Doxey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356606917 PECOS PAC ID: 5597065946 Enrollment ID: I20151208000826 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Kim D York |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205207768 PECOS PAC ID: 9537466792 Enrollment ID: I20160401002013 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Shunta L Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871027516 PECOS PAC ID: 1658642483 Enrollment ID: I20170811002108 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Christina Marie Peters |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851767149 PECOS PAC ID: 5294042925 Enrollment ID: I20170815002537 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Joanne N Gipson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053844290 PECOS PAC ID: 5799118774 Enrollment ID: I20191205000278 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
| Provider Name | Robin Michelle Donaldson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073106191 PECOS PAC ID: 0941616981 Enrollment ID: I20210317000675 |
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
News Archive
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
A selection of health policy stories from North Carolina, California and Virginia.
New reseach reveals that women who have a child after experiencing fertility problems are more likely to remain with their partner following infertility evaluations.
› Verified 7 days ago
Slucare Department Of Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1225 South Grand, 2l, Door 3,4, St Louis, MO 63104 Phone: 314-977-6164 | |
Generations Family Medicine Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1035 Bellevue Ave, Suite 206, St Louis, MO 63117 Phone: 314-781-4922 Fax: 314-645-0158 | |
Jianmei Liu, Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 6400 Clayton Ave, Suite 401, St Louis, MO 63117 Phone: 314-644-6500 Fax: 314-644-6501 | |
John M Laird Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3009 N Ballas Road, Suite 230a, St Louis, MO 63131 Phone: 314-872-3620 Fax: 314-872-9003 | |
Midwest Gastroenterology & Hepatology Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 621 S New Ballas Rd, #1001b, St Louis, MO 63141 Phone: 314-251-5660 Fax: 314-251-5663 | |
Rheumatology & Internal Medicine Associates Of West County Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3023 N Ballas Road, Professional Office Building D Suite 500, St Louis, MO 63131 Phone: 314-567-4541 Fax: 314-569-3647 |